More than 40,000 PET procedures were performed between April 1 and June 30, 2001, according to a quarterly study by IMV Medical Information Division. The numbers represent a 7% increase over fourth quarter 2000, during which an estimated 37,400
More than 40,000 PET procedures were performed between April 1 and June 30, 2001, according to a quarterly study by IMV Medical Information Division. The numbers represent a 7% increase over fourth quarter 2000, during which an estimated 37,400 procedures were performed. Driving this surge are oncology procedures, which make up the highest proportion of PET studies. These are followed by neurology and cardiology applications. IMV estimates that 510 facilities in the U.S. performed PET procedures during 2Q 2001. While the majority of sites used coincidence cameras to carry out the studies, more procedures were actually conducted using dedicated PET scanners.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.